AXIM Biotechnologies, Inc.
AXIM
$0.003
$0.000.00%
| 06/30/2024 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -66.98% | 310.85% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -66.98% | 310.85% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -70.38% | 310.85% | |||
| SG&A Expenses | 41.70% | -46.48% | |||
| Depreciation & Amortization | 0.09% | 1.12% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 28.34% | -40.36% | |||
| Operating Income | -40.80% | 46.36% | |||
| Income Before Tax | -676.53% | 84.63% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -676.53% | 84.63% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -676.53% | 84.63% | |||
| EBIT | -40.80% | 46.36% | |||
| EBITDA | -55.63% | 54.20% | |||
| EPS Basic | -618.18% | 86.25% | |||
| Normalized Basic EPS | -585.71% | 72.00% | |||
| EPS Diluted | -809.09% | 91.41% | |||
| Normalized Diluted EPS | -585.71% | 72.00% | |||
| Average Basic Shares Outstanding | 10.53% | 9.61% | |||
| Average Diluted Shares Outstanding | 10.53% | 9.61% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
